Exane Derivatives’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $2.78K | Sell |
69
-815
| -92% | -$32.9K | ﹤0.01% | 414 |
|
|
2022
Q1 | $58.6K | Sell |
884
-177
| -17% | -$11.7K | 0.02% | 554 |
|
|
2021
Q4 | $106K | Sell |
1,061
-1,405
| -57% | -$141K | 0.03% | 431 |
|
|
2021
Q3 | $308K | Sell |
2,466
-226
| -8% | -$28.3K | 0.07% | 273 |
|
|
2021
Q2 | $326K | Sell |
2,692
-522
| -16% | -$63.2K | 0.07% | 255 |
|
|
2021
Q1 | $491K | Sell |
3,214
-1,394
| -30% | -$213K | 0.14% | 142 |
|
|
2020
Q4 | $594K | Buy |
4,608
+2,878
| +166% | +$371K | 0.17% | 118 |
|
|
2020
Q3 | $193K | Buy |
+1,730
| New | +$193K | 0.06% | 196 |
|